1.
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer o...
by Groll, Andreas H, Prof
The lancet oncology, 2014, Vol.15 (8), p.e327-e340
2.
Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment
by Chng, Kern Rei
Nature Medicine, 2020, Vol.26 (6), p.941-951
3.
Fungal infections in HIV/AIDS
by Limper, Andrew H
The Lancet infectious diseases, 2017, Vol.17 (11), p.e334-e343
4.
Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study
by Teillant, Aude, MS
The Lancet infectious diseases, 2015, Vol.15 (12), p.1429-1437
5.
X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations
by Aadam, Zahra
Journal of clinical immunology, 2016, Vol.36 (3), p.187-194
6.
Emerging opportunistic yeast infections
by Miceli, Marisa H, MD
The Lancet infectious diseases, 2011, Vol.11 (2), p.142-151
7.
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-gr...
by Peter, Jonny G, PhD
The Lancet (British edition), 2016, Vol.387 (10024), p.1187-1197
8.
The HIV-associated tuberculosis epidemic—when will we act?
by Harries, Anthony D, Prof
The Lancet (British edition), 2010, Vol.375 (9729), p.1906-1919
9.
Tuberculosis control and elimination 2010–50: cure, care, and social development
by Lönnroth, Knut, Dr
The Lancet (British edition), 2010, Vol.375 (9728), p.1814-1829
10.
Neglected endemic mycoses
by Queiroz-Telles, Flavio
The Lancet infectious diseases, 2017, Vol.17 (11), p.e367-e377
11.
Bacterial pneumonia in kidney transplant recipients
by Wilmes, D
Respiratory medicine, 2018, Vol.137, p.89-94
12.
Multidrug-resistant bacteria in solid organ transplant recipients
by Cervera, C
Clinical microbiology and infection, 2014, Vol.20 (s7), p.49-73
13.
Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment
by Abbott, Iain J
Expert review of anti-infective therapy, 2011, Vol.9 (4), p.471-488
14.
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
by Greenberg, J D
Annals of the rheumatic diseases, 2010, Vol.69 (2), p.380-386
15.
Invasive fungal infections in solid organ transplant recipients
by Gavaldà, J
Clinical microbiology and infection, 2014, Vol.20 (s7), p.27-48
16.
The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation
by Chung, Pooi Yin
FEMS microbiology letters, 2016, Vol.363 (20), p.fnw219
17.
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
by Baddley, John W
Annals of the Rheumatic Diseases, 2014, Vol.73 (11), p.1942-1948
18.
From the classic concepts to modern practice
by Fishman, J.A
Clinical microbiology and infection, 2014, Vol.20 (s7), p.4-9
19.
Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
by San-Juan, R
Clinical microbiology and infection, 2014, Vol.20 (s7), p.109-118
20.
Mechanisms of Bacterial Colonization of the Respiratory Tract
by Siegel, Steven J
Annual review of microbiology, 2015, Vol.69 (1), p.425-444
